<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Z</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>National Institute of Food and Agriculture</funding><pagination>158870</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7979545</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1866(3)</volume><pubmed_abstract>Linoleic acid (LNA)-derived 13-hydroxyoctadecadienoic acid (13-HODE) is a bioactive lipid mediator that regulates multiple signaling processes in vivo. 13-HODE is also produced when LNA is oxidized during food processing. However, the absorption and incorporation kinetics of dietary 13-HODE into tissues is not known. The present study measured unesterified d4-13-HODE plasma bioavailability and incorporation into rat liver, adipose, heart and brain following gavage or intravenous (IV) injection (n = 3 per group). Mass spectrometry analysis revealed that d4-13-HODE was absorbed within 20 min of gavage, and continued to incorporate into plasma esterified lipid fractions throughout the 90 min monitoring period (incorporation half-life of 71 min). Following IV injection, unesterified d4-13-HODE was rapidly eliminated from plasma with a half-life of 1 min. Analysis of tracer incorporation kinetics into rat tissues following IV injection or gavage revealed that the esterified tracer preferentially incorporated into liver, adipose and heart compared to unesterified d4-13-HODE. No tracer was detected in the brain. This study demonstrates that dietary 13-HODE is absorbed, and incorporated into peripheral tissues from esterified plasma lipid pools. Understanding the chronic effects of dietary 13-HODE exposure on peripheral tissue physiology and metabolism merits future investigation.</pubmed_abstract><journal>Biochimica et biophysica acta. Molecular and cell biology of lipids</journal><pubmed_title>Linoleic acid-derived 13-hydroxyoctadecadienoic acid is absorbed and incorporated into rat tissues.</pubmed_title><pmcid>PMC7979545</pmcid><funding_grant_id>R21 HD095391</funding_grant_id><funding_grant_id>P30 ES023513</funding_grant_id><funding_grant_id>R21 ES032990</funding_grant_id><pubmed_authors>Emami S</pubmed_authors><pubmed_authors>Lein PJ</pubmed_authors><pubmed_authors>Lerno LA</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Taha AY</pubmed_authors><pubmed_authors>Slupsky CM</pubmed_authors><pubmed_authors>Hennebelle M</pubmed_authors><pubmed_authors>Morgan RK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Linoleic acid-derived 13-hydroxyoctadecadienoic acid is absorbed and incorporated into rat tissues.</name><description>Linoleic acid (LNA)-derived 13-hydroxyoctadecadienoic acid (13-HODE) is a bioactive lipid mediator that regulates multiple signaling processes in vivo. 13-HODE is also produced when LNA is oxidized during food processing. However, the absorption and incorporation kinetics of dietary 13-HODE into tissues is not known. The present study measured unesterified d4-13-HODE plasma bioavailability and incorporation into rat liver, adipose, heart and brain following gavage or intravenous (IV) injection (n = 3 per group). Mass spectrometry analysis revealed that d4-13-HODE was absorbed within 20 min of gavage, and continued to incorporate into plasma esterified lipid fractions throughout the 90 min monitoring period (incorporation half-life of 71 min). Following IV injection, unesterified d4-13-HODE was rapidly eliminated from plasma with a half-life of 1 min. Analysis of tracer incorporation kinetics into rat tissues following IV injection or gavage revealed that the esterified tracer preferentially incorporated into liver, adipose and heart compared to unesterified d4-13-HODE. No tracer was detected in the brain. This study demonstrates that dietary 13-HODE is absorbed, and incorporated into peripheral tissues from esterified plasma lipid pools. Understanding the chronic effects of dietary 13-HODE exposure on peripheral tissue physiology and metabolism merits future investigation.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T19:54:10.462Z</modification><creation>2025-04-04T19:54:10.462Z</creation></dates><accession>S-EPMC7979545</accession><cross_references><pubmed>33340768</pubmed><doi>10.1016/j.bbalip.2020.158870</doi></cross_references></HashMap>